Testing neonateinfant membrane oxygenators with the University of Texas neonatal pulsatile cardiopulmonary bypass system in vitro

Ündar, A.; Holland, M.C.; Howelton, R.V.; Benson, C.K.; Ybarra, J.R.; Miller, O.L.; Rossbach, M.M.; Runge, M.M.; Johnson, S.B.; Sako, E.Y.; Calhoon, J.H.
September 1998
Perfusion;1998, Vol. 13 Issue 5, p346
Academic Journal
Neurologic complications are already well documented after cardiopulmonary bypass (CPB) procedures in neonates and infants. Physiologic pulsatile flow CPB systems may be the alternative to the currently used steady-flow CPB circuits. In addition to the pulsatile pump, a membrane oxygenator should be chosen carefully, because only a few membrane oxygenators are suitable for physiologic pulsatile flow. We have tested four different types of neonateinfant membrane oxygenators for physiologic pulsatility with The University of Texas neonateinfant pulsatile CPB system in vitro. Evaluation criteria were based on mean ejection time, extracorporeal circuit (ECC) pressure, and upstroke of dp/dt. The results suggested that the Capiox 308 hollow-fibre membrane oxygenator produced the best physiologic pulsatile waveform according to the ejection time, ECC pressure, and the upstroke of dp/dt. The Minimax Plus and Masterflo Infant hollow-fibre membrane oxygenators also produced adequate pulsatile flow. Only the Variable Prime Cobe Membrane Lung (VPCML) Plus flat-sheet membrane oxygenator failed to reach the criteria for physiologic pulsatility. Depending on the oxygenator used, the lowest priming volume of the infant CPB circuit was 415 ml and the highest 520 ml.


Related Articles

  • Editorial. Taylor, K. // Perfusion;1998, Vol. 13 Issue 3, p155 

    Editorial. Discusses on the ability of membrane oxygenators to handle and remove air. Quantification and localization of the air removal characteristics of membrane oxygenators; Analysis on the design and manufacture of cardiopulmonary bypass circuit components for neonatal and pediatric...

  • Can an oxygenator design potentially contribute to air embolism in cardiopulmonary bypass? A novel method for the determination of the air removal capabilities of neonatal membrane oxygenators. de Somer, F.; Dierickx, P.; Dujardin, D.; Verdonck, P.; Nooten, G.V. // Perfusion;1998, Vol. 13 Issue 3, p157 

    At present, air handling of a membrane oxygenator is generally studied by using an ultrasonic sound bubble counter. However, this is not a quantitative method and it does not give any information on where air was entrapped in the oxygenator and if it eventually was removed through the membrane...

  • Air trapping ability of the Spiral Goldâ„¢ membrane oxygenator: an ex vivo study. Mueller, Xavier M; Tevaearai, Hendrick T; van Ness, Karen; Horisberger, Judith; Augstburger, Monique; Burki, Marco; von Segesser, Ludwig K // Perfusion;1998, Vol. 13 Issue 1 

    Despite an overall improvement in cardiopulmonary bypass (CPB) technology and materials, air emboli still occur. The latest generation membrane oxygenator from Bentley Laboratories, the SpiralGoldâ„¢, was tested ex vivo for its air handling ability. The study was conducted on four calves....

  • High risk of intraoperative awareness during cardiopulmonary bypass with isoflurane administration via diffusion membrane oxygenators. Philipp, A; Wiesenack, C; Behr, R; Schmid, FX; Birnbaum, DE // Perfusion;May2002, Vol. 17 Issue 3, p175 

    In cardiac surgery with the aid of extracorporeal circulation (ECC), inhalation anaesthetics can be administered via the oxygenator. Until the recent advent of a new type of diffusion membrane oxygenator, we routinely added the inhalation agent, isoflurane, to the gas flow of a microporous...

  • The need for an organized ECMO-based respiratory program in Japan. Hashimoto, Satoru // Journal of Anesthesia;2012, Vol. 26 Issue 5, p647 

    The author suggests the importance of an organized extracorporeal membrane oxygenation (ECMO)-based respiratory program in Japan. He describes ECMO as an expanded clinical application of cardiopulmonary bypass introduced in the 1950s that allowed a longer period of support than other...

  • Effect of Carmeda® BioActive Surface coating versus Trilliumâ„¢ Biopassive Surface coating of the oxygenator on circulating platelet count drop during cardiopulmonary bypass. Palanzo, D.A.; Zarro, D.L.; Manley, N.J.; Montesano, R.M.; Quinn, M.; Elmore, B-A.; Gustafson, P.A.; Castagna, J.M. // Perfusion;Jul2001, Vol. 16 Issue 4, p279 

    An investigation was conducted to evaluate the effect that surface coating of the hollow-fiber membrane oxygenator had on circulating platelet count drop during cardiopulmonary bypass (CPB). Sixty patients undergoing non-emergency myocardial revascularization for coronary artery disease were...

  • Institutional experience with extracorporeal membrane oxygenation in lung transplantation Aigner, Clemens; Wisser, Wilfried; Taghavi, Shahrokh; Lang, György; Jaksch, Peter; Czyzewski, Damian; Klepetko, Walter // European Journal of Cardio-Thoracic Surgery;Mar2007, Vol. 31 Issue 3, p468 

    Abstract: Background: Extracorporeal membrane oxygenation (ECMO) is currently accepted in lung transplantation either to bridge patients to transplantation or to treat postoperatively arising severe primary graft failure. Based on promising initial experiences we have since 2001 implemented ECMO...

  • Extracorporeal membrane oxygenation, an anesthesiologist's perspective: Physiology and principles. Part 1. Chauhan, Sandeep; Subin, S. // Annals of Cardiac Anaesthesia;Sep2011, Vol. 14 Issue 3, p218 

    Extracorporeal membrane oxygenation (ECMO) is an adaptation of conventional cardiopulmonary bypass techniques to provide cardiopulmonary support. ECMO provides physiologic cardiopulmonary support to aid reversible aspects of the disease process and to allow recovery. ECMO does not provide...

  • Extracorporeal Membrane Oxygenation: Quo Vadis? Betit, Peter // Respiratory Care;Jul2009, Vol. 54 Issue 7, p948 

    Extracorporeal membrane oxygenation, a form of artificial circulatory support, continues to evolve beyond its well-established neonatal applications. It is often the most aggressive aspect of treatment algorithms in the management of severe respiratory and cardiac failure. While its use is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics